ROSA MARÍA
AYALA DÍAZ
Profesora asociada de Ciencias de la Salud
University of Texas MD Anderson Cancer Center
Houston, Estados UnidosPublications in collaboration with researchers from University of Texas MD Anderson Cancer Center (3)
2023
-
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
The Lancet, Vol. 401, Núm. 10373, pp. 269-280
2013
-
Inhibition of related JAK/STAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm
British Journal of Haematology, Vol. 161, Núm. 5, pp. 667-676
-
Proteomic analysis reveals heat shock protein 70 has a key role in polycythemia Vera
Molecular Cancer, Vol. 12, Núm. 1